This Article Full Text Full Text (PDF) All Versions of this Article: 92/11/4332    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gathercole, L. L. Articles by Tomlinson, J. W. Search for Related Content PubMed PubMed Citation Articles by Gathercole, L. L. Articles by Tomlinson, J. W. Related Collections Diabetes and Insulin Metabolism

Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue

Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TT, United Kingdom

Address all correspondence and requests for reprints to: Dr. Jeremy W. Tomlinson, Ph.D., M.R.C.P., Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham B15 2TT, United Kingdom. E-mail: J.W.Tomlinson{at}bham.ac.uk.

Context: Glucocorticoid (GC) excess is characterized by central obesity, insulin resistance, and in some cases, type 2 diabetes. However, the impact of GC upon insulin signaling in human adipose tissue has not been fully explored.

Objective: We have examined the effect of GC upon insulin signaling in both human sc primary preadipocyte cultures and a novel human immortalized sc adipocyte cell line (Chub-S7) and contrasted this with observations in primary cultures of human skeletal muscle.

Design and Setting: This is an in vitro study characterizing the impact of GC upon insulin signaling in human tissues.

Patients: Biopsy specimens were from healthy volunteers who gave their full and informed written consent.

Interventions: Combinations of treatments, including GC, RU38486, and wortmannin, were used.

Main Outcome Measures: Insulin signaling cascade gene and protein expression and insulin-stimulated glucose uptake were determined.

Results: In human adipocytes, pretreatment with GC induced a dose-dependent [1.0 (control); 1.2 ± 0.1 (50 nM); 2.2 ± 0.2 (250 nM), P < 0.01 vs. control; 3.4 ± 0.2 (1000 nM), P < 0.001 vs. control] and time-dependent [1.0 (1 h); 3.2 ± 2.0 (6 h); 9.1 ± 5.9 (24 h), P < 0.05 vs. 1 h; 4.5 ± 2.2 (48 h)] increase in insulin-stimulated protein kinase B/akt phosphorylation. In addition, whereas insulin receptor substrate (IRS)-1 protein expression did not change, IRS-1 tyrosine phosphorylation increased. Furthermore, GC induced IRS-2 mRNA expression (2.8-fold; P < 0.05) and increased insulin-stimulated glucose uptake [1.0 (control) 1.8 ± 0.1 (insulin) vs. 2.8 ± 0.2 (insulin + GC); P < 0.05]. In contrast, in primary cultures of human muscle, GC decreased insulin-stimulated glucose uptake [1.0 (control) 1.9 ± 0.2 (insulin) vs. GC 1.3 ± 0.1 (insulin + GC); P < 0.05].

Conclusions: We have demonstrated tissue-specific regulation of insulin signaling by GC. Within sc adipose tissue, GCs augment insulin signaling, yet in muscle GCs cause insulin resistance. We propose that enhanced insulin action in adipose tissue increases adipocyte differentiation, thereby contributing to GC-induced obesity.

This article has been cited by other articles:

				J. W. Tomlinson, J. Finney, B. A. Hughes, S. V. Hughes, and P. M. Stewart Reduced Glucocorticoid Production Rate, Decreased 5{alpha}-Reductase Activity, and Adipose Tissue Insulin Sensitization After Weight Loss Diabetes, June 1, 2008; 57(6): 1536 - 1543. [Abstract] [Full Text] [PDF]